首页|肺癌并发静脉血栓栓塞症的临床特征及风险因素分析

肺癌并发静脉血栓栓塞症的临床特征及风险因素分析

扫码查看
目的 汇总、对比、剖析肺癌并发静脉血栓栓塞症(VTE)患者的临床特点,为临床诊断和防治提供依据.方法 回顾性分析2017年1月至2023年12月海军军医大学第二附属医院收治入院肺癌患者的临床资料,筛选出肺癌并发VTE患者63例(VTE组),选择同时入院的肺癌患者63例(非VTE组).比较并分析了2组患者性别、年龄、身体质量指数、合并症、肺癌TNM分期、肿瘤类型、治疗方式、实验室检查及肿瘤标志物等,进一步分析肺癌并发VTE的临床特征及风险因素.结果 VTE组在高龄、糖尿病、肿瘤TNM分期Ⅲ/Ⅳ期的发病率明显高于非VIE组,差异均有统计学意义[(67.23±8.39)岁vs(60.21±7.28)岁,39.7%vs 15.9%,69.8%vs 47.6%;P<0.05或P<0.01];VTE组在呼吸困难、心悸、肢体疼痛肿胀的发生率上均高于非VTE组,差异具有统计学意义(58.7%vs 36.5%,55.6%vs 28.6%,60.3%vs 0;P<0.05);2组实验室检验纤维蛋白原、总胆固醇、低密度脂蛋白、铁蛋白、D-二聚体比较,差异具有统计学意义(P<0.05或P<0.01).VTE组发生肺栓塞(PE)和深静脉栓塞(DVT)分别为27.0%vs 73.0%(P<0.05)o2组患者Logistic回归分析结果表明,Ⅲ/Ⅳ期肺癌患者并发VTE的危险性较Ⅰ/Ⅱ期肺癌患者高(P<0.05),D-二聚体升高是肺癌患者出现VTE的风险因素(P<0.01).结论 肺癌并发VTE的可能性大,高龄、合并糖尿病更易发生,肺癌Ⅲ/Ⅳ期、D-二聚体升高是肺癌患者并发VTE的风险因素.这提示临床应对于合并以上风险因素的患者给予防治血栓方面的更大关注.
Analysis of clinical characteristics and risk factors of lung cancer complicated with venous thromboembo-lism
Objective To summarize,compare and analyze the clinical process of patients with lung cancer complicated with venous thromboembolism(VTE)to provide the basis for clinical diagnosis.Methods Clinical data of lung cancer patients admitted to our hospital from January 2017 to December 2023 were selected.63 patients with lung cancer complicated with VTE were screened out(VTE group),and 63 patients with lung cancer admitted at the same time(non-VTE group)were selected.Gender,age,body mass index,comorbidities,time of diagnosis of lung cancer,clinical stage of lung cancer,type of lung cancer,treatment,and laboratory tumor marker data of the two groups were compared and analyzed.The clinical characteristics and risk factors of lung cancer complicated with VTE were further analyzed.Results The incidence of age,diabetes and TNM Stage Ⅲ/Ⅳ in VTE group was significantly higher than that in non-VTE group,the difference was significant[(67.23±8.39)years vs 60.21±7.28)years,39.7%vs 15.9%,69.8%vs 47.6%,P<0.05 or P<0.01].The incidence of dyspnea,palpitation and limb pain and swelling in lung cancer patients with VTE was higher than that in lung cancer patients(58.7%vs 36.5%,55.6%vs 28.6%,60.3%vs 0,P<0.05).Laboratory tests of fibrinogen,total cholesterol,low density lipoprotein,ferritin and D-dimer were sig-nificantly better than lung cancer patients(P<0.05 or P<0.01).The incidence of pulmonary embolism and deep VTE was 27.0%vs 73.0%,respectively(P<0.05).Logistic regression analysis showed that the risk of VTE in patients with Ⅲ/Ⅳ lung cancer was higher than that in patients with stage Ⅰ/Ⅱ lung cancer(P<0.05).Increased D-dimer was a risk factor for VTE in lung cancer patients(P<0.01).Conclusion VTE is more likely to occur in lung cancer patients,and it is more likely to occur in old age and diabetes melli-tus.Stage Ⅲ/Ⅳ lung cancer and D-dimer increase are independent risk factors for VTE in lung cancer patients.It suggests that we should pay more attention to the prevention and treatment of thrombus in patients with the above risk factors.

lung cancervenous thromboembolismpulmonary embolismD-Dimerclinical stage

张云雁

展开 >

200003 上海,海军军医大学第二附属医院呼吸与危重症医学科

肺癌 静脉栓塞症 肺栓塞 D-二聚体 临床分期

2024

医学研究生学报
南京军区南京总医院

医学研究生学报

CSTPCD北大核心
影响因子:1.652
ISSN:1008-8199
年,卷(期):2024.37(9)